Renata Boschi Portella
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Renata Boschi Portella has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Marco Aurelio Vinhosa Bastos Junior
FAMED UFMS
2 shared publications Anna Gabriela Fuks
Universidade do Estado do Rio de Janeiro
1 shared publication- Cristiane Moulin de Moraes
Departamento de Endocrinologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, Rua Dr. Enéas de Carvalho Aguiar 255, São Paulo, SP, Brazil
1 shared publication Décio Iandoli
Anhanguera-Uniderp University, Rua Ceará, 333 - Miguel Couto, Campo Grande, MS 79003-010, Brazil
1 shared publicationEdna F. Cunha
Universidade do Estado do Rio de Janeiro
1 shared publication- Giancarlo Lucchetti
Department of Medicine, School of Medicine, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Brazil
1 shared publication
Latest Publications
- Open Access
- 13 June 2023
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 17 (1) , 1-10
Insulinoma with peripheral neuropathy: a case report
Background: Insulinomas are rare neuroendocrine tumors that typically present with hypoglycemic crises. Peripheral neuropathy is an uncommon complication of insulinoma. Most clinicians expect peripheral neuropathy symptoms to reverse completely after the insulin-secreting tumor is resected, but this may be a misassumption. Case report: We report a case of a 16-year-old Brazilian boy with clonic muscle spasms of the lower limbs for almost one year. Disabling paraparesis and confusional episodes had progressively set in as well. There were no sensorial abnormalities in the lower limbs, upper limbs or cranial nerves. An electromyography revealed a motor neuropathy of the lower limbs. The diagnosis of insulinoma was established as serum insulin and C-peptide concentrations were inappropriately normal during spontaneous episodes of hypoglycemia. Following a normal abdominal magnetic resonance scan, the imaging work-up continued with an endoscopic ultrasound, which localized the tumor at the pancreatic body-tail transition. Once localized, a prompt surgical removal (enucleation) of the tumor was undertaken, leading to an immediate and complete resolution of hypoglycemia. The time length between the onset of symptoms and tumor resection was 15 months. After surgery, the symptoms of peripheral neuropathy of the lower limbs showed a slow and only partial improvement. At a two-year follow-up after surgery, although being able to lead a normal and productive life, the patient still reported symptoms of reduced muscular strength in the lower limbs and a new electroneuromyography analysis showed chronic denervation and reinnervation in the legs’ muscles—indicating chronic neuropathic injury. Conclusion: The events of this case reinforce the importance of an agile diagnostic work-up and spry definitive treatment for patients with this uncommon disease, enabling the cure of neuroglycopenia before permanent bothersome complications ensue.
- 13 June 2023
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 17 (1) , 1-10
Open AccessInsulinoma with peripheral neuropathy: a case report
Background: Insulinomas are rare neuroendocrine tumors that typically present with hypoglycemic crises. Peripheral neuropathy is an uncommon complication of insulinoma. Most clinicians expect peripheral neuropathy symptoms to reverse completely after the insulin-secreting tumor is resected, but this may be a misassumption. Case report: We report a case of a 16-year-old Brazilian boy with clonic muscle spasms of the lower limbs for almost one year. Disabling paraparesis and confusional episodes had progressively set in as well. There were no sensorial abnormalities in the lower limbs, upper limbs or cranial nerves. An electromyography revealed a motor neuropathy of the lower limbs. The diagnosis of insulinoma was established as serum insulin and C-peptide concentrations were inappropriately normal during spontaneous episodes of hypoglycemia. Following a normal abdominal magnetic resonance scan, the imaging work-up continued with an endoscopic ultrasound, which localized the tumor at the pancreatic body-tail transition. Once localized, a prompt surgical removal (enucleation) of the tumor was undertaken, leading to an immediate and complete resolution of hypoglycemia. The time length between the onset of symptoms and tumor resection was 15 months. After surgery, the symptoms of peripheral neuropathy of the lower limbs showed a slow and only partial improvement. At a two-year follow-up after surgery, although being able to lead a normal and productive life, the patient still reported symptoms of reduced muscular strength in the lower limbs and a new electroneuromyography analysis showed chronic denervation and reinnervation in the legs’ muscles—indicating chronic neuropathic injury. Conclusion: The events of this case reinforce the importance of an agile diagnostic work-up and spry definitive treatment for patients with this uncommon disease, enabling the cure of neuroglycopenia before permanent bothersome complications ensue.
- Open Access
- 1 December 2003
- Published by FapUNIFESP (SciELO) in Archives of Endocrinology and Metabolism
- Vol. 47 (6) , 677-683
Prevalência de sobrepeso e obesidade em pacientes com diabetes tipo 1
Para avaliar a prevalência de sobrepeso e obesidade em diabéticos tipo 1 (DM1), estudamos 170 pacientes (89F/81M; 14 crianças, 51 adolescentes e 105 adultos, com 24,4±11,9 anos) e correlacionamos seus dados antropométricos com fatores demográficos e clínicos. A prevalência de obesidade, sobrepeso e/ou risco de sobrepeso foi de 21,2% (n= 36). Houve uma correlação de 0,97 entre o score z do IMC e o percentil do IMC (p= 0,00) no grupo de crianças e adolescentes. Houve diferença na PAS (p= 0,004) e na PAD (p= 0,0007) entre pacientes com IMC normal e alterado. Ocorreu uma tendência a um aumento progressivo da medida da cintura com os níveis de PA (p= 0,0000). O IMC foi dependente da idade (OR: 1,04, 95% IC = 1,01-1,07; p= 0,008) na análise multivariada. Na análise stepwise, a PAS foi dependente da cintura (r= 0,57; p= 0,00) e da idade (r= 0,63; p= 0,00) e a PAD, da cintura (r= 0,53; p= 0,00). A prevalência de sobrepeso e obesidade nos DM1 parece refletir a tendência mundial de aumento de peso e suas conseqüências clínicas, reforçando a necessidade do controle de peso nestes pacientes.
- 1 December 2003
- Published by FapUNIFESP (SciELO) in Archives of Endocrinology and Metabolism
- Vol. 47 (6) , 677-683
Open AccessPrevalência de sobrepeso e obesidade em pacientes com diabetes tipo 1
Para avaliar a prevalência de sobrepeso e obesidade em diabéticos tipo 1 (DM1), estudamos 170 pacientes (89F/81M; 14 crianças, 51 adolescentes e 105 adultos, com 24,4±11,9 anos) e correlacionamos seus dados antropométricos com fatores demográficos e clínicos. A prevalência de obesidade, sobrepeso e/ou risco de sobrepeso foi de 21,2% (n= 36). Houve uma correlação de 0,97 entre o score z do IMC e o percentil do IMC (p= 0,00) no grupo de crianças e adolescentes. Houve diferença na PAS (p= 0,004) e na PAD (p= 0,0007) entre pacientes com IMC normal e alterado. Ocorreu uma tendência a um aumento progressivo da medida da cintura com os níveis de PA (p= 0,0000). O IMC foi dependente da idade (OR: 1,04, 95% IC = 1,01-1,07; p= 0,008) na análise multivariada. Na análise stepwise, a PAS foi dependente da cintura (r= 0,57; p= 0,00) e da idade (r= 0,63; p= 0,00) e a PAD, da cintura (r= 0,53; p= 0,00). A prevalência de sobrepeso e obesidade nos DM1 parece refletir a tendência mundial de aumento de peso e suas conseqüências clínicas, reforçando a necessidade do controle de peso nestes pacientes.